Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias

International Journal of Cardiology

Volumn 64, Issue 1, 1998, Pages 37-45

  Hsieh, Ming Hsiung ^a   Chen, Shih Ann ^a   Wen, Zu Chin ^a   Tai, Ching Tai ^a   Chiang, Chern En ^a   Ding, Yu An ^a   Chang, Mau Song ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT; PROCAINAMIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; EXERCISE TEST; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FUNCTION TEST; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; TILTING; TREADMILL EXERCISE;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROCAINAMIDE; PROPAFENONE; SOTALOL; TILT-TABLE TEST; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032513180     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00330-6     Document Type: Article

References (31)

1. Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJet al. Management of patients with atrial fibrillation. Circulation. 93:1996;1262-1277.
2. Lip GYH, Watson RDS, Singh SP Drugs for atrial fibrillation. Br Med J. 311:1995;1631-1634.
3. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
4. Mason JW, The ESVEM Investigators A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic drug efficacy for ventricular tachyarrhythmias. N Engl J Med. 329:1993;452-458.
5. Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J. 106:1983;501-504.
6. Antman EM, Beamer AD, Cantillon C, McGowan N, Goldman L, Friedman PL Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 12:1988;1005-1011.
7. Reimold SC, Cantillon CO, Friedman PL, Antman EM Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 71:1993;558-563.
8. Juul-Moller S, Edvardsson N, Rehnqvist-Ahlberg N Sotalol versus quinidine for maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 82:1990;1932-1939.
9. Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol. 28:1996;700-706.
10. Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SPet al. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial. J Intern Med. 239:1996;253-260.
11. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Chen YJet al. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. Am J Cardiol. 79:1997;905-908.
12. Chen SA, Lee SH, Chiang CE, Tai CT, Wu TJ, Cheng CCet al. Electrophysiological mechanisms in successful radiofrequency catheter modification of atrioventricular junction for patients with medically refractory paroxysmal atrial fibrillation. Circulation. 93:1996;1690-1701.
13. Moe GK, Abildskov JA Observations on the ventricular dysrhythmia associated with atrial fibrillation in the dog heart. Circ Res. 14:1964;447-460.
14. Langendorf R, Pick A, Katz LN Ventricular response in atrial fibrillation: role of concealed conduction in the AV node. Circulation. 32:1965;69-75.
15. Zipes DP, Mendez C, Moe GK Evidence for summation and voltage dependency in rabbit atrioventricular nodal fibers. Circ Res. 32:1973;170-177.
16. Janse MJ Influence of the direction of the atrial wave front on AV nodal transmission in isolated hearts of rabbit. Circ Res. 25:1969;439-449.
17. Wittkampf FHM, De Jonngste MJL, Meijler FL Competitive antegrade and retrograde atrioventricular junctional activation in atrial fibrillation. J Cardiovasc Electrophysiol. 1:1990;448-456.
18. Chorro FJ, Kirchhof CJHJ, Brugada J, Allessie MA Ventricular response during irregular atrial pacing and atrial fibrillation. Am J Physiol. 259:1990;H1015-H1021.
19. Stein KM, Borer JS, Hochreiter C, Devereux RB, Kligfield P Variability of the ventricular response in atrial fibrillation and prognosis in chronic non-ischemic mitral regurgitation. Am J Cardiol. 74:1994;906-911.
20. Frey B, Heinz G, Blinder T, Wutte M, Schneider B, Schmidinger Het al. Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. Am Heart J. 129:1995;58-65.
21. Hnatkova K, Murgatroyd FD, Camm AJ, Malik M Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 19(Pt II):1996;1968-1971.
22. Hohnloser SH, Woosley RL Drug therapy: sotalol. N Engl J Med. 331:1994;31-38.
23. Kirsh JA, Sahakian AV, Baerman JM, Swiryn S Ventricular response to atrial fibrillation: role of atrioventricular conduction pathways. J Am Coll Cardiol. 12:1988;1265-1272.
24. van den Berg MP, de Langen CDJ, Bel JHKJ, Crijns HJGM, Dijk WA, Lie KI Analysis of randomness of atrial and ventricular rhythm in atrial fibrillation. Eur Heart J. 16:1995;971-976.
25. Kaufman ES, Bosner MS, Bigger JT, Stein PK, Kleiger RE, Rolnitzky LMet al. Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects. Am J Cardiol. 72:1993;95-99.
26. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation. 90:1994;1826-1831.
27. Atwood JE, Sullivan M, Forbes S, Myers J, Pewen W, Olson HGet al. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol. 10:1987;314-320.
28. Lundstrom T, Ryden L Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J Am Coll Cardiol. 16:1990;86-90.
29. Steinberg JS, Katz RJ, Bren GB, Buff LA, Varghese PJ Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise. J Am Coll Cardiol. 9:1987;405-411.
30. Atwood JE, Myers JN, Sullivan MJ, Forbes SM, Pewen WF, Froelicher VF Diltiazem and exercise performance in patients with chronic atrial fibrillation. Chest. 92:1988;20-25.
31. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.